Abstract
Abstract
Background
Female genital mutilation/cutting (FGM/C) is a clear violation of women’s rights and can have adverse and irreversible health effects as well. Worldwide, more than 200 million women and girls have undergone FGM/C. Utility value of FGM/C has not been estimated yet, so we designed this study to extract the health utility value of FGM/C for the first time in the world.
Methods
In a cross-sectional study in Iran, 125 girls and women who underwent FGM/C procedure were examined by the trained midwives in order to determine its type. In addition, a questionnaire was completed for identifying the socio-demographic factors and extracting the health utility of these individuals. Health utility was measured using Time Trade-off method and also to determine the effects of the socio-demographic factors on the health utility a two-limit censored regression model was applied.
Results
The mean and median of the health utility of women with FGM/C were 0.971 (SE: 0.003) and 0.968 (IQR: 1–0.95), respectively. Number of non-traders was 58 (46.4%) who reported perfect health utility. However, the mean of health utility among traders was 0.946 (SE: 0.002). Only type 1 (Clitoridectomy) and type 2 (Excision) FGM/C were seen in this study. Women with Type 1 FGM/C had significantly lower health utility value (Mean: 0.968, Median: 0.957) than their type 2 counterparts (Mean: 0.987, Median: 1.00). Moreover, women in the age group of 31–45 years (Mean: 0.962, Median: 0.956), single (Mean: 0.950, Median: 0.954), divorced (Mean: 0.951, Median: 0.950), employed (Mean: 0.959, Median: 0.956), and with supplementary insurance (Mean: 0.962, Median: 0.950) had significantly lower health utility than their counterparts.
Conclusion
FGM/C affects physical and psychological well-being of these individuals, resulting in a lack of personal and marital satisfaction, which ultimately leads to a 3% reduction in their health related quality of life. Therefore, preventing from this practice is very important and should be considered by health system policy makers more than before.
Funder
Kurdistan University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference41 articles.
1. Organization WH. WHO guidelines on the management of health complications from female genital mutilation: policy brief. Geneva: World Health Organization; 2016.
2. Unicef. Female Genital Mutilation/cutting: a Global Concern. UNICEF's Data Work on FGM/C: Unicef; 2016. https://www.unicef.org/media/files/FGMC_2016_brochure_final_UNICEF_SPREAD.pdf.
3. Ahmed MR, Shaaban MM, Meky HK, Amin Arafa ME, Mohamed TY, Gharib WF, ABJTEJoC A, Care RH. Psychological impact of female genital mutilation among adolescent Egyptian girls: a cross-sectional study. Eur J Contracept Reprod Health Care. 2017;22(4):280–5.
4. United Nations Children's Fund, Gupta GR. Female genital mutilation/cutting: a statistical overview and exploration of the dynamics of change. Reproductive Health Matters. 2013. pp.184-190. https://www.jstor.org/stable/43288321?seq=1.
5. Van Baelen L, Ortensi L, EJTEJoC L, Care RH. Estimates of first-generation women and girls with female genital mutilation in the European Union, Norway and Switzerland. Eur J Contracept Reprod Health Care. 2016;21(6):474–82.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献